HALEY STOWE: Open Payments
NPI 1174168892 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 42 payments from 14 companies in 2025. Trend: 2023 $277 · 2024 $1,250 · 2025 $904
Food & beverage: $804Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $199 |
| UCB, Inc. | 6 | $170 |
| Lilly USA, LLC | 5 | $79 |
| Regeneron Healthcare Solutions, Inc. | 4 | $78 |
| GENZYME CORPORATION | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| ABBVIE INC. | 4 | $62 |
| Galderma Laboratories, L.P. | 3 | $49 |
| LEO Pharma Inc. | 2 | $31 |
| Genentech USA, Inc. | 1 | $26 |
Products named: TREMFYA, Bimzelx, DUPIXENT, TALTZ, NEMLUVIO, COSENTYX, RINVOQ, SKYRIZI.
Industry payments across MI — which companies pay providers there.
